JAMA Dermatology

JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

[JAMA Dermatology @JAMADerm]

💬 Editorial: In advanced #MycosisFungoides and #SézarySyndrome, the Cutaneous Lymphoma International Prognostic Index may help identify patients at diagnosis who need closer monitoring, different treatment intensity, or clinical trial consideration.

https://t.co/WeCNe2eofc

[JAMA Dermatology @JAMADerm]

A 1-time hydrocolloid dressing may be a safe, convenient option after skin surgery, according to a randomized clinical trial in JAMA Dermatology. #Dermatology #SkinSurgery

📌 Learn more: https://t.co/UHk8xA1fhV

[JAMA Dermatology @JAMADerm]

Among children of #Melanoma survivors, a telehealth behavioral intervention did not reduce sunburn over time vs an active control, but it was associated with lower child-reported sunburn immediately postintervention and better #SunProtection behaviors.

https://t.co/w67yolmf0T

[JAMA Dermatology @JAMADerm]

🎧 Listen to an interview with Yelena P. Wu, PhD, author of "Melanoma Prevention Among Children of Melanoma Survivors: A Randomized Clinical Trial" with Adewole S. Adamson, MD, MPP.

https://t.co/1PsivG0e4O

[JAMA Dermatology @JAMADerm]

Inflation-adjusted Medicare reimbursement for common #Dermatology procedures declined from 2007 to 2026, with most of the decline occurring after 2021. https://t.co/AAg68V1XeX

[JAMA @JAMA_current]

📣 @JAMA_current and the @JAMANetwork journals are issuing a call for papers on Women's Health.

Last year, we launched @JAMAWomenHealth, an initiative that offers expertly curated research and insights from work published in JAMA and the JAMA Network. An important goal of JAMA+ Women's Health is to shift the conversation about women’s health beyond the “usual” categories of #reproductive #health, #pregnancy, #menopause, and certain #cancers.

To align with the 2027 International Women’s Day, JAMA and the JAMA Network journals will publish women’s health articles across the full spectrum of health care on March 8, 2027.

This call for papers will prioritize timely and novel research articles and opinion manuscripts. Manuscripts submitted by November 15, 2026, will have the best chance for consideration for simultaneous publication on International Women’s Day.

🔗 Click on the link to read the full editorial: https://t.co/lEU7MgyDEY

[AMA Ed Hub™ @AMAEdHub]

Epidermoid cyst or dilated pore of Winer? A man in his 70s presented with a 1×1 cm subcutaneous nodule with a central punctum on the left thigh. Share your diagnosis on this @JAMADerm Clinical Challenge. https://t.co/r6C3gSPPaU

[AMA Ed Hub™ @AMAEdHub]

Do these symptoms suggest verrucous venous malformation?

A patient presented with warty plaques on the left lower limb. Examination revealed erythematous papules, verrucous plaques and mass-like proliferative lesions. What's your diagnosis? @JAMADerm https://t.co/rovIXef0Yh

[JAMA Dermatology @JAMADerm]

📄 This case report describes a pendulous hyperpigmented lesion with a ridged bag-of-worms surface, multiple café-au-lait macules, and axillary freckling across the patient’s trunk and arm.

https://t.co/dOjY9o438Q

[JAMA Dermatology @JAMADerm]

Among patients with advanced #MycosisFungoides and #SézarySyndrome, higher Cutaneous Lymphoma International Prognostic Index scores were associated with shorter progression-free survival and lower likelihood of response.

https://t.co/tW2lB07xlg

[JAMA Dermatology @JAMADerm]

💬 Editorial: In advanced #MycosisFungoides and #SézarySyndrome, the Cutaneous Lymphoma International Prognostic Index may help identify patients at diagnosis who need closer monitoring, different treatment intensity, or clinical trial consideration.

https://t.co/cSzRmgZ2Q7

[JAMA Dermatology @JAMADerm]

Among children of #Melanoma survivors, a telehealth behavioral intervention did not reduce sunburn over time vs an active control, but it was associated with lower child-reported sunburn immediately postintervention and better #SunProtection behaviors.

https://t.co/RWzgA8TKaf

[JAMA Dermatology @JAMADerm]

#Melasma is a skin condition that causes dark patches on the face.

This JAMA Dermatology Patient Page describes the causes, symptoms, diagnosis, and treatment of melasma.

https://t.co/Px7eWiNSMb

[JAMA Dermatology @JAMADerm]

📄 This case report describes a patient with adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome with solitary plasmacytoma. https://t.co/ke5heiVgm7

[JAMA Dermatology @JAMADerm]

📄 This case report describes 2 patients with pruritic plaques and follicular papules. https://t.co/YVHU1SJEUi

[JAMA Dermatology @JAMADerm]

Can a blood test help detect Merkel cell carcinoma recurrence? A JAMA Dermatology study suggests that tracking polyomavirus antibody titers after surgery may be used to monitor for #cancer recurrence.
#SkinCancer

📌 Read full article to learn more: https://t.co/k2Th6W18Qn

[JAMA Dermatology @JAMADerm]

#POTS was more prevalent in patients with classic #Dermatomyositis than in those with cutaneous lupus erythematosus or lupus overlap, regardless of autoantibody status. https://t.co/tMDQ6f3B5m

[JAMA Dermatology @JAMADerm]

Listen to Keith A. Choate, MD, PhD, discuss his JAMA Dermatology article which investigates how longitudinal growth patterns in children with epidermal differentiation disorders vary by genotype with Adewole S. Adamson, MD, MPP. https://t.co/rK2Y9AAdVo

[JAMA Dermatology @JAMADerm]

Among dermatology patients, note viewing in the electronic portal was positively associated with new visits, procedures, and female dermatologists, but lower among Black, Hispanic, male, or non–English-speaking patients. https://t.co/DrO5UcoGBK

[JAMA Dermatology @JAMADerm]

Among 2 patients with refractory #Pemphigus, B-cell maturation antigen–targeted T-cell engager therapy was associated with rapid B-cell depletion, desmoglein antibody loss, and remission of clinical disease activity. https://t.co/J14zoHXkp5